Serial Number | 78282972 |
Word Mark | CADUET |
Filing Date | Monday, August 4, 2003 |
Status | 601 - ABANDONED - EXPRESS |
Status Date | Sunday, February 22, 2004 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease |
Goods and Services | Medical information services, namely, providing information in the field of cardiovascular disorders, hypertension and cholesterol reduction |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 19, 2003 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 19, 2003 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Pfizer Inc |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New York, NY 10017 |
Event Date | Event Description |
Sunday, February 22, 2004 | ABANDONMENT - EXPRESS MAILED |
Wednesday, February 18, 2004 | ASSIGNED TO EXAMINER |
Monday, December 29, 2003 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Monday, December 29, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, December 29, 2003 | PAPER RECEIVED |